Cargando…
Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
Sublines from the small cell lung cancer (SCLC) cell lines U1285 and U1690, denoted U1285-100, U1285-250, U1690-40 and U1690-150, were adapted to grow in the continuous presence of 100, 250, 40 and 150 ng ml-1 doxorubicin (Dox), respectively. The Dox resistance was accompanied by cross-resistance to...
Autores principales: | Nygren, P., Larsson, R., Gruber, A., Peterson, C., Bergh, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977853/ https://www.ncbi.nlm.nih.gov/pubmed/1684906 |
Ejemplares similares
-
Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil.
por: Twentyman, P. R., et al.
Publicado: (1990) -
Verapamil potentiation of doxorubicin resistance development in B16 melanoma cells both in vitro and in vivo.
por: Formelli, F., et al.
Publicado: (1988) -
In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015) -
Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
por: Sehested, M., et al.
Publicado: (1990) -
Synergistic Effect of Cyclosporin A and Verapamil in Overcoming Vincristine Resistance of Multidrug‐resistant Cultured Human Leukemia Cells
por: Ishida, Yasushi, et al.
Publicado: (1990)